MannKind Corp Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

MannKind Corp Stock Summary

MannKind Corp competes with Cue Biopharma, Eliem Therapeutics, Inhibrx, and Molecular Partners. MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Mannkind Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 348 people.

MannKind Corp Key Financial Ratios

MannKind Corp Key Balance Sheet Accounts

MannKind Corp Key Income Statement Accounts

MannKind Corp Key Cash Accounts

MannKind Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MannKind Corp's current stock value. Our valuation model uses many indicators to compare MannKind Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MannKind Corp competition to find correlations between indicators driving MannKind Corp's intrinsic value. More Info.MannKind Corp is considered to be number one stock in return on asset category among its peers. It is regarded second in profit margin category among its peers fabricating about  0.88  of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for MannKind Corp is roughly  1.13 . At present, MannKind Corp's Net Loss is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value MannKind Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

MannKind Corp Systematic Risk

Today, most investors in MannKind Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MannKind Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MannKind Corp growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of MannKind Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MannKind Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of MannKind Corp based on widely used predictive technical indicators. In general, we focus on analyzing MannKind Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MannKind Corp's daily price indicators and compare them against related drivers.

When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.